ABDOMINAL AORTIC ANEURYSM (Screening)

Evidence Statement Benefit Plan Language Other Information and Resources Author(s)

References


Updated 11/17/11

Evidence Statement

Clinical Preventive Service Recommendations

U.S. Preventive Services Task Force Recommendation
The U.S. Preventive Services Task Force (USPSTF) recommends one-time screening for abdominal aortic aneurysm (AAA) by ultrasonography in men aged 65 to 75 who have ever smoked.1

Evidence Rating: B (Recommended/At Least Fair Evidence)
The USPSTF found good evidence that screening for AAA and surgical repair of large AAAs (5.5 cm or more) in men aged 65 to 75 who have ever smoked (current and former smokers) leads to decreased AAA-specific mortality. There is good evidence that abdominal ultrasonography, performed in a setting with adequate quality assurance (i.e., in an accredited facility with credentialed technologists), is an accurate screening test for AAA. There is also good evidence of important harms of screening and early treatment, including an increased number of surgeries with associated clinically-significant morbidity and mortality, and short-term psychological harms. Based on the moderate magnitude of net benefit, the USPSTF concluded that the benefits of screening for AAA in men aged 65 to 75 who have ever smoked outweigh the harms.1

NOTE:
The USPSTF recommends against routine screening for AAA in certain populations. For more information, see D recommendations.

The USPSTF makes no recommendations for or against screening for AAA in certain populations. For more information, see C recommendations.

Back to top


The Value of Prevention

Economic Burden of Condition/Disease
An estimate of the total societal economic burden of AAA is not available. However, hospital discharge data from Health Cost and Utilization Project (HCUP) show that, in 2003, 45,986 patients were discharged with AAA (without rupture) with a mean length of stay of 6.7 days and aggregate charges of $2.7 billion.12 Therefore, the average AAA patient staying in the hospital cost more than $59,000. Hospital discharge data also show that in 2003, 6,815 patients were discharged with a ruptured AAA with a mean length of stay of 10.7 days and total charges of $639.71 million. The average cost per discharge for a ruptured AAA exceeded $93,000. Men accounted for 75% of all discharges and 80% of aggregate charges.12

The economic burden of AAA would be much larger if lost productivity, premature mortality, and morbidity costs were accounted for.
Workplace Burden of Condition/Disease
Detailed data on the workplace burden of AAA is not available. The workplace burden of AAA is likely to increase due to the rapidly aging workforce.
Economic Benefit of Preventive Intervention
Early detection and appropriate management of AAA through screening can prevent costs resulting from rupture or leakage. The average cost of emergency surgery for AAA is approximately $50,000, while elective surgery (following AAA screening) is only $25,000.13
Estimated Cost of Preventive Intervention
In 2004, the private-sector cost of screening for AAA averaged $115; approximately 95% of all paid claims fell within the range of $35 to $336.14
Estimated Cost of Treatment
The average cost of surgery for AAA is between $25,000 and $50,000 (in year 2004 dollars).13
Cost-Effectiveness and/or Cost-Benefit Analysis of Preventive Intervention
The Oregon Evidence-Based Practice Center (EPC) conducted an evidence synthesis of AAA screening studies.15-18 Their principal findings point to a cost-effectiveness ratio for population-based AAA screening (compared with no screening) that lies in the range of $14,000 to $20,000 per quality-adjusted life year (QALY).10 In comparison to other preventive interventions and to commonly accepted cost-effectiveness benchmarks, screening for AAA is cost-effective.

Back to top


Condition / Disease Specific Information

Epidemiology of Condition/Disease
An abdominal aortic aneurysm (AAA) is a potentially fatal abnormal swelling (often balloon-like) of a segment of the body's largest artery, the aorta. The wall of the artery bulges out rather than remaining straight.2

Abdominal aortic aneurysms are found in 4% to 8% of older men and 0.5% to 1.5% of older women.3-6 Aortic aneurysms account for approximately 15,000 deaths in the United States annually; of these, 9,000 are AAA-related and the remainder are due to thoracic aortic aneurysms.7-8

Once an aortic aneurysm develops, it is a lifelong condition. Most abdominal aortic aneurysms grow larger with time, expanding at an average rate of .33 centimeters to .5 centimeters each year. Approximately 17% of AAAs eventually rupture if left untreated.9 In about 20% of cases, an undiscovered abdominal aneurysm ruptures without warning and the patient collapses and dies from massive bleeding inside the abdomen. Most AAAs do not cause any symptoms, however when present, symptoms may include:

  • Pain in the abdomen, back, or the fleshy part of sides between the bottom ribs and the hips.
  • A feeling of fullness after eating a small meal.
  • Nausea and vomiting.
  • A pulsating mass in the abdomen.

Condition/Disease Risk Factors
Older age, smoking, male sex, and family history are the most significant AAA risk factors.3 Other risk factors include high blood pressure, high blood cholesterol levels, and obesity.10 Approximately 69% of men in the United States age 65 to 74 years are current or former smokers and are therefore at risk for AAA.7 A former smoker, also called an "ever smoker" is defined as anyone with a lifetime consumption of more than 100 cigarettes.11

Back to top


Preventive Intervention Information

Preventive Intervention: Purpose of Screening
Screening for AAA allows clinicians to identify affected patients and those who require preventive surgery and can thereby prevent rupture or leakage of the aneurysm.

Early intervention reduces AAA-specific mortality15 and is more cost-effective than emergency surgery.13
Benefits and Risks of Intervention
Ultrasonography of the abdomen is accurate19 and reliable15 in detecting AAAs and it does not expose patients to radiation. One-time AAA ultrasound screening and the surgical repair of large AAAs (5.5 centimeters or more) in men aged 65 to 75 who have ever smoked reduces AAA-related mortality by as much as 43%.15 The USPSTF found good evidence of important harms associated with screening and early treatment, including an increased number of surgeries with clinically-significant morbidity and mortality, and short-term psychological harms. Based on the moderate magnitude of net benefit, the USPSTF concluded that the benefits of screening for AAA in men aged 65 to 75 who have ever smoked outweigh the harms.1
Initiation, Cessation, and Interval of Screening
The USPSTF recommends a one-time screening ultrasound to look for abdominal aortic aneurysm in men aged 65 to 75 who have smoked at any time in their lives. The exact timing of the screen is left to the discretion of the clinician.1
Intervention Process
Ultrasonography of the abdomen is used to screen for AAA. Ultrasonography should be performed in an accredited facility with credentialed technologists.
Treatment Information
Treatment depends on the size of the aneurysm. The larger the aneurysm, the more likely it is to burst (rupture). Death rates for ruptured aneurysms and emergency surgery are higher than rates for scheduled repair of unruptured aneurysms. Surgery is almost always recommended for an aneurysm that is leaking. Surgery is generally recommended for people with aneurysms larger than 5.5 centimeters in diameter unless another illness makes surgery unusually risky. Even with no symptoms, a person with an aneurysm larger than 6.5 centimeters would almost always have urgent surgery to repair the problem. People with smaller aneurysms may be monitored with ultrasound tests (every 12 months for anyone with an aneurysm smaller than 3.5 centimeters and every six months for those with aneurysms larger than 3.5 centimeters) to determine if the aneurysm is growing larger.2

Health benefits should include provisions for follow-up and treatment.

Back to top


Strength of Evidence

The level of evidence supporting the recommendations contained in this chapter is described below.

Evidence-Based Research:
U.S. Preventive Service Task Force (USPSTF)
Strength of Evidence: B (Recommended/At Least Fair Evidence)
  • The USPSTF recommends one-time screening for abdominal aortic aneurysm (AAA) by ultrasonography in men aged 65 to 75 who have ever smoked.2

Back to top


Summary Plan Description

Covered Screening
Ultrasonography of the abdomen.
Initiation, Cessation, and Interval
One-time screening ultrasound to look for abdominal aortic aneurysm in men aged 65 to 75 who have smoked at any time in their lives. The exact timing of the screen is left to the discretion of the clinician.

Back to top


CPT Codes

Abdominal Aortic Aneurysm (Screening)
76700 Abdominal ultrasound, complete
76705 Abdominal ultrasound, limited (eg, single organ, quadrant, follow-up)

Back to top


Other Information and Resources

Business Group Resource(s)

CDC Resource

Back to top


Author(s)

Lanza A, Sotnikov S, Vandiver KP. Abdominal aortic aneurysm evidence-statement: screening. In: Campbell KP, Lanza A, Dixon R, Chattopadhyay S, Molinari N, Finch RA, editors. A Purchaser's Guide to Clinical Preventive Services: Moving Science into Coverage. Washington, DC: National Business Group on Health; 2006. Updated 2011.

Back to top


References

  1. U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm. Recommendation statement. AHRQ Publication No. 05-0569-A. Rockville, MD: Agency for Healthcare Research and Quality; Feb 2005. Available at: http://www.ahrq.gov/clinic/uspstf05/aaascr/aaars.htm.
  2. Harvard Medical School, Aetna. Abdominal aortic aneurysm. Available at: http://www.intelihealth.com/IH/ihtIH/WSIHW000/9339/31040.html. Accessed May 14, 2009.
  3. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med. 2000;160:1425-30.
  4. Lederle FA, Johnson GR, Wilson SE. Abdominal aortic aneurysm in women. J Vasc Surg. 2001;34:122-6.
  5. Norman PE, Jamrozik K, Lawrence-Brown MM, Dickinson JA. Western Australian randomized controlled trial of screening for abdominal aortic aneurysm [Abstract]. Br J Surg. 2003;90:492.
  6. Vardulaki KA, Walker NM, Couto E, et al. Late results concerning feasibility and compliance from a randomized trial of ultrasonographic screening for abdominal aortic aneurysm. Br J Surg. 2002;89:861-4.
  7. National Center for Health Statistics. Table 1. Deaths, percent of total deaths, and death rates for the 10 leading causes of death in selected age groups, by race and sex: United States, 2000. National Vital Statistics Report; 2002.Available at: www.cdc.gov/nchs/fastats/pdf/nvsr50_16t1.pdf. Accessed May 14, 2009.
  8. Kent, K et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. Journal of Vascular Surgery. 2010; 52(3): 539-548.
  9. McPhee, J, Hill, J and Eslami, M. The impact of gender on presentation, therapy, and mortality of abdominal aortic aneurysm in the United States, 2001-2004. Journal of Vascular Surgery. 2007; 45(5): 891-899.
  10. Meenan RT, Fleming C, Whitlock EP, Beil TL, Smith P. Cost-effectiveness analyses of population-based screening for abdominal aortic aneurysm: Evidence synthesis No. 159. AHRQ Electronic Newsletter Issue. Rockville, MD: Agency for Healthcare Research and Quality; February 4, 2005. Available at: http://ahrq.gov/news/enews/enews159.htm. Accessed May 14, 2009.
  11. Schoenborn CA, Adams PF, Barnes PM, Vickerie JL, Schiller JS. Health behaviors of adults: United States, 1999-2001. National Center for Health Statistics. Companion Table 4.1. Vital Health Statistics. 2004;10(219). Available at: http://www.cdc.gov/nchs/data/series/sr_10/sr10_219companion.pdf. Accessed May 14, 2009.
  12. Agency for Healthcare Research and Quality. Hospital Cost and Utilization Project: Nationwide inpatient sample data set. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
  13. Silverstein MD, Pitts SR, Chaikof EL, Ballard DJ. Abdominal aortic aneurysm: Cost-effectiveness of screening, surveillance of intermediate sized AAA, and management of symptomatic AAA. Proc (Barl Univ Med Centr). 2005 Oct;18(4):345-67.
  14. Thomson Medstat. Marketscan. 2004.
  15. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: A best-evidence systematic review for the U.S. Preventive Services Task Force (Conducted by the Oregon Evidence-based Practice Center under Contract No. 290-02-0024, Task Order Number 2). Rockville, MD: Agency for Healthcare Research and Quality; 2005. Available at: http://www.ahrq.gov/clinic/prevenix.htm.
  16. Multicentre Aneurysm Screening Study Group. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from a randomised controlled trial. BMJ. 2002;325:1135-8.
  17. Soisalon-Soininen S, Rissanen P, Pentikäinen T, Mattila T, Salo JA. Cost-effectiveness of screening for familial abdominal aortic aneurysms. VASA. 2001;30:262-70.
  18. Lee TY, Korn P, Heller JA, et al. The cost-effectiveness of a "quick-screen" program for abdominal aortic aneurysms. Surgery. 2002;132(2):399-407.
  19. Wilmink AB, Forshaw M, Quick CR, Hubbard CS, Day NE. Accuracy of serial screening for abdominal aortic aneurysms by ultrasound. J Med Screen. 2002;9:125-7.